Hi all! For this time, our lecturer ask we to do the User Centere Design Assignment. Basically we need to create screens design based on different user's characteristic.
TOPIC : CHIKUNGUNYA
TARGET AUDIENCE :
1) ADULTS (30 and above years old)
-parents
-folks
-public/private sector workers
-lectures
2) TEENAGERS (14 – 29 years old)
-secondary school students
-college students
-volunteers
3) KIDS ( 3 – 12 years old)
-primary school students
-kindergarden
-volunteers
PRECEDENT STUDIES
1) SCREEN DESIGN 1 (ADULTS)
- such a formal
- as a serious design
- have a matured message
- based on feedback surveys form
2) SCREEN DESIGN 2 (TEENAGERS)
- more contemporary
- cool design which send a serious message to a teenagers
- attractive and versatile
- based on feedback surveys form
3) SCREEN DESIGN 3 (KIDS)
- attractive
- not a bores and not many word
- put a kids element
- base on feedback surveys form
CHIKUNGUNYA
Key facts
• Chikungunya is a viral disease that is spread by mosquitoes. It causes fever and severe joint pain. Other symptoms include muscle pain, headache, nausea, fatigue and rash.
• The disease shares some clinical signs with dengue, and can be misdiagnosed in areas where dengue is common.
• There is no cure for the disease. Treatment is focused on relieving the symptoms.
• The proximity of mosquito breeding sites to human habitation is a significant risk factor for chikungunya.
• The disease occurs in Africa, Asia and the Indian subcontinent. In recent decades mosquito vectors of chikungunya have spread to Europe and the Americas. In 2007, disease transmission was reported for the first time in Europe, in a localized outbreak in north-eastern Italy.
Chikungunya is a mosquito-borne viral disease first described during an outbreak in southern Tanzania in 1952. It is an alphavirus of the family Togaviridae. The name ‘chikungunya’ derives from a root verb in the Kimakonde language, meaning "to become contorted" and describes the stooped appearance of sufferers with joint pain.
Signs and symptoms
Chikungunya is characterized by an abrupt onset of fever frequently accompanied by joint pain. Other common signs and symptoms include muscle pain, headache, nausea, fatigue and rash. The joint pain is often very debilitating, but usually ends within a few days or weeks. Most patients recover fully, but in some cases joint pain may persist for several months, or even years. Occasional cases of eye, neurological and heart complications have been reported, as well as gastrointestinal complaints. Serious complications are not common, but in older people, the disease can contribute to the cause of death. Often symptoms in infected individuals are mild and the infection may go unrecognized, or be misdiagnosed in areas where dengue occurs
Transmission
The virus is transmitted from human to human by the bites of infected female mosquitoes. Most commonly, the mosquitoes involved are Aedes aegypti and Aedes albopictus, two species which can also transmit other mosquito-borne viruses, including dengue. These mosquitoes can be found biting throughout daylight hours, although there may be peaks of activity in the early morning and late afternoon. Both species are found biting outdoors, but Ae. aegypti will also readily feed indoors.
After the bite of an infected mosquito, onset of illness occurs usually between four and eight days but can range from two to 12 days.
Diagnosis
Several methods can be used for diagnosis. Serological tests, such as enzyme-linked immunosorbent assays (ELISA), may confirm the presence of IgM and IgG anti-chikungunya antibodies. IgM antibody levels are highest three to five weeks after the onset of illness and persist for about two months. The virus may be isolated from the blood during the first few days of infection. Various reverse transcriptase–polymerase chain reaction (RT–PCR) methods are available but are of variable sensitivity. Some are suited to clinical diagnosis. RT–PCR products from clinical samples may also be used for genotyping of the virus, allowing comparisons with virus samples from various geographical sources.
Treatment
There are no specific drugs to cure the disease. Treatment is directed primarily at relieving the symptoms, including the joint pain. There is no commercial chikungunya vaccine.
Prevention and control
The proximity of mosquito vector breeding sites to human habitation is a significant risk factor for chikungunya as well as for other diseases that these species transmit. Prevention and control relies heavily on reducing the number of natural and artificial water-filled container habitats that support breeding of the mosquitoes. This requires mobilization of affected communities. During outbreaks, insecticides may be sprayed to kill flying mosquitoes, applied to surfaces in and around containers where the mosquitoes land, and used to treat water in containers to kill the immature larvae.
For protection during outbreaks of chikungunya, clothing which minimizes skin exposure to the day-biting vectors is advised. Repellents can be applied to exposed skin or to clothing in strict accordance with product label instructions. Repellents should contain DEET (N, N-diethyl-3-methylbenzamide), IR3535 (3-[N-acetyl-N-butyl]-aminopropionic acid ethyl ester) or icaridin (1-piperidinecarboxylic acid, 2-(2-hydroxyethyl)-1-methylpropylester). For those who sleep during the daytime, particularly young children, or sick or older people, insecticide treated mosquito nets afford good protection. Mosquito coils or other insecticide vaporizers may also reduce indoor biting.
Disease outbreaks
Chikungunya occurs in Africa, Asia and the Indian subcontinent. Human infections in Africa have been at relatively low levels for a number of years, but in 1999-2000 there was a large outbreak in the Democratic Republic of the Congo, and in 2007 there was an outbreak in Gabon.
Starting in February 2005, a major outbreak of chikungunya occurred in islands of the Indian Ocean. A large number of imported cases in Europe were associated with this outbreak, mostly in 2006 when the Indian Ocean epidemic was at its peak. A large outbreak of chikungunya in India occurred in 2006 and 2007. Several other countries in South-East Asia were also affected. In 2007 transmission was reported for the first time in Europe, in a localized outbreak in north-eastern Italy.
More about disease vectors
Both Ae. aegypti and Ae. albopictus have been implicated in large outbreaks of chikungunya. Whereas Ae. aegypti is confined within the tropics and sub-tropics, Ae. albopictus also occurs in temperate and even cold temperate regions. In recent decades Ae. albopictus has spread from Asia to become established in areas of Africa, Europe and the Americas.
The species Ae. albopictus thrives in a wider range of water-filled breeding sites than Ae. aegypti, including coconut husks, cocoa pods, bamboo stumps, tree holes and rock pools, in addition to artificial containers such as vehicle tyres and saucers beneath plant pots. This diversity of habitats explains the abundance of Ae. albopictus in rural as well as peri-urban areas and shady city parks. Ae. aegypti is more closely associated with human habitation and uses indoor breeding sites, including flower vases, water storage vessels and concrete water tanks in bathrooms, as well as the same artificial outdoor habitats as Ae. albopictus.
In Africa several other mosquito vectors have been implicated in disease transmission, including species of the A. furcifer-taylori group and A. luteocephalus. There is evidence that some animals, including non-primates, may act as reservoirs.
References :
3) http://en.wikipedia.org/wiki/Chikungunya
Basically, i'm also doing my online survey question for get the public audience feedback reagrding this topic.
Here is my online survey form,
Basically the results is :
For Question,
1) Adults, 40%, Teenagers, 40%, Kids , 20%
2) 60% that answered the survey is Malaysian, and 40% is foreigner
3) 75% that answered the survey is Male, and 25% is Female
4) Most of 85% of them, know what is the Chikungunya
5) The Social Network is mostly nowdays preferred media, that win by 65% compared than the others
6) 55% of them, already use the computer around 5 - 10 years
7) The most preffered user interface is the 3D Animation, thats scored 45% than the others
THE COMPOSITION
Based on my survey for target audience, here is my design composition that i've made,
1) SCREEN DESIGN 1 (ADULTS)
- based on feedback surveys form
SCREEN DESIGN : (DYNAMIC FLASH WEBPAGE/BANNER)
2) SCREEN DESIGN 2 (TEENAGERS)
- cool design which send a serious message to a teenagers
- attractive and versatile
- based on feedback surveys form
SCREEN DESIGN : (FIRST PERSON SHOOTER VIDEO GAME INTERFACE)
3) SCREEN DESIGN 3 (KIDS)
- not a bores and not many word
- base on feedback surveys form
SCREEN DESIGN : (INTERACTIVE FLASH MOVIE)
PREVIOUS WORK
Here is the previous example that design by the others regarding Chikungunya and my preffered screen design.
example of flash screen design
example of Malaria Poster in Latin
Example of Dengue Poster by Ministry of Heath
Example of Promotion/ Awareness Campaign by Goverment Regarding Aedes
The Dengue Posters
Example of Dynamic Flash Web Screen Design
The example of Malaria Awareness Program Poster
The cartoon that show People and Mosquitoes
The example of dynamic corporate flash web design
The templates of Flash Project/Movie
MY WORKS
My first design before my lecturer ask me to repair it,
Adults Screen Design
Kids Screen Design
Teenagers Screen Design
Mr. Bad ask me to put some of button to really shows it is a screen design and not a poster, he also reminds me about the Typography mistakes in kids design. Im also need to put out the 3 symbols that i use both in adults and teenagers screen design.
FINAL DESIGN
Adults Screen Design (Flash Ads/Flash Web)
Teen Screen Design (First Person Shooter Video Game Interface)
Kids Screen Design (Interactive Flash Movie)
That's all for my 2nd Design Process Digital Media 3 Assignments, Thank you
